Publications

Reichert H, McMahon LF, Meddings J. Risk-adjusting hospital-acquired pressure ulcer rates from administrative data: How do hospitals perform by the risk-adjusted AHRQ Patient Safety Indicator 3 compared to a proposed measure using risk-standardization applied by the Centers for Medicare and Medicaid Services for other outcomes? Presented at the Academy Health Annual Research Meeting, San Diego, CA, June 2014.

Meddings J, Reichert H, Dueweke E, Rhyner J. 2014. Issues regarding identification of urinary catheter use from medical records. In: Battles JB, Cleeman JI, Kahn KK, and Weinberg DA, eds. Advances in the Prevention and Control of Healthcare-Associated Infections. Rockville (MD): Agency for Healthcare Research and Quality (US).

Reichert H, McMahon LF, Meddings J. Hospital-acquired catheter-associated urinary tract infections: Reported by mandate to the National Healthcare Safety Network, but rarely listed as diagnoses in claims data. Presented at the Society of General Internal Medicine Annual Meeting, San Diego, CA, April 2014.

Reichert H, Meddings J. What’s so standard about risk standardization? Presented at the 2014 American Statistical Association (ASA) Conference on Statistical Practice, Tampa, FL, February 2014.

Greene T, Kiyoshi-Teo H, Reichert H, Krein S, Saint S. 2014. Urinary catheter indications in the United States: Results from a national survey of acute care hospitals. Infect Contr Hosp Epidemiol Oct:S96-S98.

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18^th Annual International Meeting, New Montreal Quebec, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16^th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Pinto DS, Nicholson G, Harrington RA, Cyr PL, Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.